Aspiriant LLC’s Arhaus ARHS Stock Holding History

Aspiriant LLC’s Portfolio ARHS Stock Details ARHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,252	Closed	-$204K	–	287
2024 Q1	$204K	Buy	+13,252	New	+$171K	0.01%	308

Other funds holding ARHS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Aperture Investors New York $1.11B AUM 81.44% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aspiriant LLC's ARHS Position: Q2 2024 in Review

Aspiriant LLC sold out of Arhaus (ARHS) in Q2 2024, closing a stake of 13,252 shares — an estimated $204K sold.

Aspiriant LLC first reported a position in ARHS in Q1 2024 and held it in 1 quarter. The position peaked at $204K in Q1 2024. 151 funds tracked by Wall St. Rank hold ARHS as of Q2 2024.

Aspiriant LLC reported no remaining Arhaus position as of Q2 2024 after selling out during the quarter.
Aspiriant LLC sold 13,252 Arhaus shares in Q2 2024, an estimated $204K.
Aspiriant LLC first reported a position in Arhaus in Q1 2024 and held it in 1 quarter.
Aspiriant LLC's Arhaus position peaked at $204K in Q1 2024.
151 funds tracked by Wall St. Rank held Arhaus as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.